Trade-Off Between Lipid-Lowering Therapy and Costs in Patients With Cardiovascular Disease
-
- Ishii Hideki
- Department of Cardiology, Nagoya University Graduate School of Medicine
-
- Murohara Toyoaki
- Department of Cardiology, Nagoya University Graduate School of Medicine
Bibliographic Information
- Other Title
-
- Cost-Effectiveness of PCSK9 Inhibitor Plus Statin in Patients With Triple-Vessel Coronary Artery Disease in Japan
Search this article
Description
<p>Background: The addition of a proprotein convertase subtilisin/kexin type 9 (PCSK9) inhibitor to statin therapy reduces the rate of cardiovascular events. This study examined the cost-effectiveness of PCSK9 inhibitor+statin compared with standard therapy (statin monotherapy) in the treatment of triple-vessel coronary artery disease (CAD) in Japan. </p><p>Methods and Results: A Markov model was applied to assess the costs and benefits associated with PCSK9 inhibitor+statin over a projected 30-year period from the perspective of a public healthcare payer in Japan. The incremental cost-effectiveness ratio (ICER), expressed as the quality-adjusted life-years (QALYs), was estimated. The effects on survival and numbers of events were based on the FOURIER trial and the CREDO Kyoto registry. The ICER of PCSK9 inhibitor+statin over standard therapy was 13.5 million (95% confidence interval 7.6–23.5 million) Japanese Yen (JPY) per QALY gained for triple-vessel CAD. The probability of the cost-effectiveness of PCSK9 inhibitor+statin vs. standard therapy was 0.0008% at a cost-effectiveness threshold of 5 million JPY. In patients with poorly controlled familial hypercholesterolemia (FH) with triple-vessel CAD, the ICER was 3.4 million JPY per QALY gained. </p><p>Conclusions: PCSK9 inhibitor plus statin did not show good cost-effectiveness for triple-vessel CAD; however, it showed good cost-effectiveness for patients with triple-vessel CAD and poorly controlled FH in Japan. </p>
Journal
-
- Circulation Journal
-
Circulation Journal 82 (10), 2481-2482, 2018-09-25
The Japanese Circulation Society
- Tweet
Details 詳細情報について
-
- CRID
- 1390001288071534336
-
- NII Article ID
- 130007486267
- 130007489796
-
- NII Book ID
- AA11591968
-
- ISSN
- 13474820
- 13469843
-
- NDL BIB ID
- 029230150
-
- Text Lang
- en
-
- Data Source
-
- JaLC
- NDL
- Crossref
- PubMed
- CiNii Articles
- KAKEN
- OpenAIRE
-
- Abstract License Flag
- Disallowed